Insufficient scRNA-seq data for expression of MAGEA12 at single-cell level.
Insufficient scRNA-seq data for expression of MAGEA12 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ureter | 0% | 0 | 0 / 0 | 100% | 37.81 | 1 / 1 |
| brain | 89% | 16.73 | 2343 / 2642 | 0% | 0 | 0 / 705 |
| skin | 2% | 0.17 | 41 / 1809 | 58% | 43.24 | 273 / 472 |
| esophagus | 6% | 0.40 | 87 / 1445 | 25% | 11.32 | 45 / 183 |
| uterus | 21% | 1.42 | 35 / 170 | 7% | 5.01 | 33 / 459 |
| prostate | 24% | 1.94 | 60 / 245 | 2% | 0.43 | 9 / 502 |
| stomach | 8% | 0.48 | 30 / 359 | 18% | 6.90 | 51 / 286 |
| lung | 3% | 0.12 | 15 / 578 | 21% | 11.90 | 246 / 1155 |
| bladder | 0% | 0 | 0 / 21 | 23% | 11.26 | 114 / 504 |
| intestine | 8% | 0.47 | 77 / 966 | 10% | 5.94 | 53 / 527 |
| liver | 1% | 0.04 | 2 / 226 | 15% | 7.85 | 62 / 406 |
| muscle | 10% | 0.67 | 84 / 803 | 0% | 0 | 0 / 0 |
| pancreas | 4% | 0.23 | 14 / 328 | 4% | 2.44 | 8 / 178 |
| breast | 2% | 0.12 | 10 / 459 | 6% | 3.09 | 70 / 1118 |
| ovary | 4% | 0.31 | 8 / 180 | 3% | 1.39 | 13 / 430 |
| kidney | 4% | 0.30 | 4 / 89 | 1% | 0.41 | 10 / 901 |
| adrenal gland | 2% | 0.18 | 5 / 258 | 3% | 0.54 | 7 / 230 |
| peripheral blood | 3% | 0.27 | 27 / 929 | 0% | 0 | 0 / 0 |
| heart | 3% | 0.15 | 22 / 861 | 0% | 0 | 0 / 0 |
| spleen | 2% | 0.14 | 6 / 241 | 0% | 0 | 0 / 0 |
| thymus | 2% | 0.29 | 15 / 653 | 0% | 0 | 0 / 605 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.23 | 1 / 45 |
| blood vessel | 1% | 0.08 | 19 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 1% | 0.35 | 15 / 1204 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0008150 | Biological process | biological_process |
| GO_0005575 | Cellular component | cellular_component |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| GO_0003674 | Molecular function | molecular_function |
| GO_0042826 | Molecular function | histone deacetylase binding |
| Gene name | MAGEA12 |
| Protein name | Melanoma-associated antigen 12 (Cancer/testis antigen 1.12) (CT1.12) (MAGE-12 antigen) (MAGE12F antigen) |
| Synonyms | MAGE12 |
| Description | FUNCTION: Not known, though may play a role tumor transformation or progression. In vitro promotes cell viability in melanoma cell lines. . |
| Accessions | ENST00000357916.8 ENST00000709994.1 P43365 ENST00000393900.4 ENST00000709993.1 ENST00000709992.1 ENST00000393869.8 |